NIFTY 50

Have requested Gilead to grant licence for Remdesivir, says Laurus Labs

Updated : May 20, 2020 04:21 PM IST

Satyanarayana Chava, Founder and CEO of Laurus Labs, said the company has requested Gilead to grant it licence for Remdesivir.

The USFDA earlier gave emergency use authorisation (EUA) to Gilead’s Remdesivir for treatment of hospitalised patients with severe COVID-19 conditions.

"We have requested them to grant license and it is up to Gilead to grant," said Chava.

Chava expects the growth trajectory to continue in the coming quarters.

“In the last few quarters, we were able to increase our gross margins and EBITDA margins, and we expect that growth trajectory will continue in the coming quarters as well,” he said.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV

recommended for you